Radiographic efficacy of adalimumab in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use and clinical response: subanalysis of adept

Documenti analoghi

• Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept
  di: Kavanaugh, A, et al.
  Pubblicazione: (2005)
• Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity
  di: Landewé, R, et al.
  Pubblicazione: (2019)
• Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
  di: Mease, P, et al.
  Pubblicazione: (2017)
• Methotrexate in psoriasis and psoriatic arthritis
  di: Coates, L, et al.
  Pubblicazione: (2020)
• Adalimumab reduces hand bone loss in rheumatoid arthritis independent of clinical response: Subanalysis of the PREMIER study
  di: Elden Aake, et al.
  Pubblicazione: (2011-02-01)